33323 Dersimelagon, a melanocortin-1 receptor agonist, maintains efficacy regardless of seasons in subjects with erythropoietic protoporphyria: Results from a post hoc analysis of phase 2 clinical trial data

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Dermatology Vol. 87; no. 3; p. AB156
Main Authors Belongie, Kirstine, Takahashi, Fumihiro, Mukai, Sakiko, Endou, Mai, Desnick, Robert
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.09.2022
Online AccessGet full text
ISSN0190-9622
1097-6787
DOI10.1016/j.jaad.2022.06.654

Cover

More Information
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2022.06.654